AstraZeneca Canada introduces new NEXIUM Patient Support program

Download PDF Copy

Sep 9 2011

NEXIUM® Prescription Benefit cards now made available online at nexiumsupport.ca

Canadian pharmaceutical company, AstraZeneca Canada Inc., has introduced a new NEXIUM® Patient Support program designed to give physicians and pharmacists the ability to take cost out of the equation in the patient's choice between NEXIUM® tablets and a generic esomeprazole product.

A prescription benefit program was implemented after a generic esomeprazole product was introduced into the Canadian market. Now, instead of patients being switched onto the generic product solely because of price differential, physicians and pharmacists can provide them with a prescription benefit smart card to bridge the financial gap and allow the choice to be made on what is right for the patient. To provide the broadest form of access to the program, a NEXIUM® website, www.nexiumsupport.ca, has been created to make electronic cards available for physicians and pharmacists to download and provide to patients.

Coincident with the prescription benefit program, AstraZeneca introduced an alternative sampling program, also based on STI's SmartTechnology platform. With this solution, new patients being initiated on NEXIUM® tablets are provided with a sample smart card by their physician, which they present at their local retail pharmacy along with their prescription. New patients then have the choice of continuing on with NEXIUM® tablets through the prescription benefit program.

The alternative sample and prescription benefit programs are currently available in Nova Scotia, New Brunswick and Ontario.

Source: STI (SAMPLING TECHNOLOGIES INC.) and CNW SOCIAL MEDIA

Posted in: Healthcare News | Pharmaceutical News

Tags: Esomeprazole, Neuroscience, Nexium, Oncology, Pharmaceuticals, Pharmacy

Comments (6)

Download PDF Copy

Comments

I am a senior on a fixed income and cannot afford Nexium

Annamarie Holtom says:

October 4, 2011 at 2:26 PM

I am a senior on a fixed income and cannot afford Nexium (which has been prescribed)or the generic drug. I have instead opted for TECTA, which is covered on the government plan. Does AstraZeneca have an assistance program for seniors?

0 0

Reply
- Audrey Feltham on AstraZeneca Canada introduces new NEXIUM Patient Support program
  
  Audrey Feltham says:
  
  August 9, 2013 at 5:15 PM
  
  I did take TECTA, it does not work for me. I took Nexium for 15 Years! Only one works for me, and I am very sick without it. Audrey P. Feltham
  
  0 0
  
  Reply
I have used Nexium by AstraZeneca without any problem,

Brent A. Brendel says:

November 13, 2013 at 8:49 AM

I have used Nexium by AstraZeneca without any problem, www.astrazeneca-us.com/.../help-affording-your-medicines

0 0

Reply
hi

Brent A. Brendel says:

November 13, 2013 at 9:13 AM

I have used Nexium for 5 year without any complaints, but prior using it I recommend to research some info and to consult the doctor as well.

0 0

Reply
Really $299 w/o insurance and $249 with insurance!

Lisa Breeden Miller says:

January 26, 2014 at 6:00 PM

I asked at my pharmacy what would be the lowest price that they could give me on my Nexium if I do not have any insurance. I was told $299.00. The tech told me that this is $100 off of the price. So I asked what it would be if applied to my insurance. I was told with my insurance and my $2500.00 deductible it would still be $249.00. My goodness. How can people afford this medication at this price and it be the only one that works for them? This is out of the question for me.

0 0

Reply
A company spokesperson said, “AstraZeneca -

Annette Williams says:

March 27, 2014 at 11:02 AM

A company spokesperson said, “AstraZeneca - www.astrazeneca-us.com/.../help-affording-your-medicines, understands that our medicines will not benefit patients if they are unable to afford them and that’s why we’ve offered patient assistance programs for more than 35 years. These programs are designed to help qualifying patients afford their medicines through a variety of channels. In 2013, AstraZeneca provided nearly $975 million in savings to more than 567,000 patients in the US through its patient assistance programs.”

Perhaps one reason Nexium is so popular (read reviews: http://medsreviews.com/drugs/nexium ) (sales exceed $6 billion annually) is because Big Pharma made it and other PPIs a household brand, through direct-to-consumer advertising. People believed from TV ads that their heartburn, which they used to treat with over-the-counter treatments like Tums, could put them at risk for gastroesophageal reflux disease (GERD).

0 0

Reply